ESR1 and breast carcinoma: To verify the cytotoxicity of the examined nanosystems to in vitro cultures, two breast cancer cell models were used: MCF-7 and MDA-MB-231 cells, which have different sensitivities to oxidative stress and estrogenic receptor expression.